VVT Med Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	0.07	0.15	0.1	0.07
Cash & Short-Term Investments	0.07	0.15	0.1	0.07
Cash Growth	15.79%	39.42%	46.48%	-
Accounts Receivable	0.03	0.03	0.03	0.03
Other Receivables	0.04	0.04	0.02	0.02
Receivables	0.07	0.07	0.05	0.05
Inventory	0.29	0.28	0.22	0.2
Other Current Assets	-	-	-	0.02
Total Current Assets	0.42	0.5	0.37	0.34
Property, Plant & Equipment	0.38	0.38	0.39	0.33
Long-Term Deferred Charges	-	-	0.19	0.19
Other Long-Term Assets	0.04	0.04	0.04	0.04
Total Assets	0.85	0.92	0.99	0.89
Accounts Payable	1.16	1.1	0.5	0.58
Accrued Expenses	-	0.37	0.45	0.45
Short-Term Debt	0.63	0.6	5.5	3.37
Current Portion of Leases	0.21	0.21	0.17	0.12
Other Current Liabilities	0.94	0.22	0.09	0.04
Total Current Liabilities	2.93	2.49	6.71	4.55
Long-Term Debt	-	-	0.37	1.34
Long-Term Leases	0.25	0.25	0.29	0.26
Other Long-Term Liabilities	-	-	-122	0.1
Total Liabilities	3.18	2.74	-114.64	6.25
Common Stock	22.95	22.93	135.6	0.01
Additional Paid-In Capital	-	-	-	13.52
Retained Earnings	-25.2	-24.64	-20.66	-19.62
Comprehensive Income & Other	-0.09	-0.11	0.69	0.72
Total Common Equity	-2.34	-1.82	115.62	-5.37
Shareholders' Equity	-2.34	-1.82	115.62	-5.36
Total Liabilities & Equity	0.85	0.92	0.99	0.89
Total Debt	1.09	1.06	6.32	5.09
Net Cash (Debt)	-1.02	-0.91	-6.22	-5.02
Net Cash Per Share	-0.02	-0.02	-0.23	-1.15
Filing Date Shares Outstanding	67.33	66.93	6.2	4.36
Total Common Shares Outstanding	67.33	66.93	4.84	4.36
Working Capital	-2.51	-2	-6.34	-4.21
Book Value Per Share	-0.03	-0.03	23.91	-1.23
Tangible Book Value	-2.34	-1.82	115.62	-5.37
Tangible Book Value Per Share	-0.03	-0.03	23.91	-1.23
Machinery	-	0.37	0.32	0.32